Published in Osteoporos Int on June 14, 2007
Incidence and mortality of hip fractures in the United States. JAMA (2009) 6.05
Meta-analysis: excess mortality after hip fracture among older women and men. Ann Intern Med (2010) 4.24
Excess mortality following hip fracture: a systematic epidemiological review. Osteoporos Int (2009) 3.74
Sedation depth during spinal anesthesia and survival in elderly patients undergoing hip fracture repair. Anesth Analg (2014) 2.24
Mortality and cause of death in hip fracture patients aged 65 or older: a population-based study. BMC Musculoskelet Disord (2011) 2.04
Clinical effectiveness of orthogeriatric and fracture liaison service models of care for hip fracture patients: population-based longitudinal study. Age Ageing (2016) 1.58
Myocardial infarction after hip fracture repair: a population-based study. J Am Geriatr Soc (2012) 1.49
Comparison of Bone Mineral Density between Urban and Rural Areas: Systematic Review and Meta-Analysis. PLoS One (2015) 1.41
Declining incidence of hip fractures and the extent of use of anti-osteoporotic therapy in Denmark 1997-2006. Osteoporos Int (2009) 1.33
Efficacy and safety of a once-yearly intravenous zoledronic acid 5 mg for fracture prevention in elderly postmenopausal women with osteoporosis aged 75 and older. J Am Geriatr Soc (2010) 1.16
Short- and long-term mortality in males and females with fragility hip fracture in Norway. A population-based study. Clin Interv Aging (2013) 1.14
Patterns of comorbidity in community-dwelling older people hospitalised for fall-related injury: a cluster analysis. BMC Geriatr (2011) 1.13
Fractures as predictors of excess mortality in the aged-a population-based study with a 12-year follow-up. Eur J Epidemiol (2008) 1.12
Type 2 diabetic mice demonstrate slender long bones with increased fragility secondary to increased osteoclastogenesis. Bone (2008) 1.03
Perioperative mortality after hemiarthroplasty related to fixation method. Acta Orthop (2011) 1.02
Morbidity and mortality in Jeju residents over 50-years of age with hip fracture with mean 6-year follow-up: a prospective cohort study. J Korean Med Sci (2013) 1.01
Mortality and osteoporotic fractures: is the link causal, and is it modifiable? Clin Exp Rheumatol (2008) 1.00
Risk of femoral shaft and subtrochanteric fractures among users of bisphosphonates and raloxifene. Osteoporos Int (2010) 0.96
Analysis of the association between bisphosphonate treatment survival in Danish hip fracture patients-a nationwide register-based open cohort study. Osteoporos Int (2012) 0.92
Burden of hip fracture on inpatient care: a before and after population-based study. Osteoporos Int (2009) 0.92
The impact of prefracture and hip fracture characteristics on mortality in older persons in Brazil. Clin Orthop Relat Res (2009) 0.90
Physical activity in middle-aged women and hip fracture risk: the UFO study. Osteoporos Int (2010) 0.89
Leisure time physical activity and risk of non-vertebral fracture in men and women aged 55 years and older: the Tromsø Study. Eur J Epidemiol (2012) 0.89
Initiation of anti-osteoporotic therapy in patients with recent fractures: a nationwide analysis of prescription rates and persistence. Osteoporos Int (2008) 0.88
A health economic analysis of osteoporotic fractures: who carries the burden? Arch Osteoporos (2013) 0.88
Skeletal health in men with chronic lung disease: rates of testing, treatment, and fractures. Osteoporos Int (2010) 0.87
The impact of care pathways for patients with proximal femur fracture: rationale and design of a cluster-randomized controlled trial. BMC Health Serv Res (2012) 0.86
Impact of heart failure on hip fracture outcomes: a population-based study. J Hosp Med (2011) 0.86
Accelerated bone loss and increased post-fracture mortality in elderly women and men. Osteoporos Int (2015) 0.86
Mortality after low trauma hip fracture: a prospective cohort study. BMC Musculoskelet Disord (2012) 0.85
Predictors of short- and long-term mortality in males and females with hip fracture - a prospective observational cohort study. PLoS One (2013) 0.85
Loss of life years after a hip fracture. Acta Orthop (2009) 0.85
Cost-effectiveness of bazedoxifene incorporating the FRAX® algorithm in a European perspective. Osteoporos Int (2010) 0.84
"The other side of the fence": a geriatric surgical case study of error disclosure. Perm J (2008) 0.84
Heterogeneity of bone microstructure in the femoral head in patients with osteoporosis: an ex vivo HR-pQCT study. Bone (2013) 0.84
Self-perceived facture risk: factors underlying women's perception of risk for osteoporotic fractures: the Risk-Stratified Osteoporosis Strategy Evaluation study (ROSE). Osteoporos Int (2014) 0.83
Linked versus unlinked hospital discharge data on hip fractures for estimating incidence and comorbidity profiles. BMC Med Res Methodol (2012) 0.82
Subsequent fracture rates in a nationwide population-based cohort study with a 10-year perspective. Osteoporos Int (2014) 0.81
Secular reduction of excess mortality in hip fracture patients >85 years. BMC Geriatr (2013) 0.81
The Immediate Intramedullary Nailing Surgery Increased the Mitochondrial DNA Release That Aggravated Systemic Inflammatory Response and Lung Injury Induced by Elderly Hip Fracture. Mediators Inflamm (2015) 0.81
Higher serum concentrations of dietary antioxidants are associated with lower levels of inflammatory biomarkers during the year after hip fracture. Clin Nutr (2012) 0.80
Association between passive smoking in adulthood and phalangeal bone mineral density: results from the KRAM study--the Danish Health Examination Survey 2007-2008. Osteoporos Int (2010) 0.80
Using vital statistics to estimate the population-level impact of osteoporotic fractures on mortality based on death certificates, with an application to France (2000-2004). BMC Public Health (2009) 0.79
Nutritional supplementation affects postoperative oxidative stress and duration of hospitalization in patients with hip fracture. Wien Klin Wochenschr (2011) 0.78
Prediction of Mortality and Postoperative Complications using the Hip-Multidimensional Frailty Score in Elderly Patients with Hip Fracture. Sci Rep (2017) 0.77
Years of life lost due to lower extremity injury in association with dementia, and care need: a 6-year follow-up population-based study using a multi-state approach among German elderly. BMC Geriatr (2016) 0.77
The effect of high dose antibiotic impregnated cement on rate of surgical site infection after hip hemiarthroplasty for fractured neck of femur: a protocol for a double-blind quasi randomised controlled trial. BMC Musculoskelet Disord (2013) 0.77
Utilization of inpatient care before and after hip fracture: a population-based study. Osteoporos Int (2008) 0.77
Is helical blade superior to screw design in terms of cut-out rate for elderly trochanteric fractures? A meta-analysis of randomized controlled trials. Eur J Orthop Surg Traumatol (2014) 0.77
Sex effects on short-term complications after hip fracture: a prospective cohort study. Clin Interv Aging (2015) 0.76
Clinical characteristics and risk factors of postoperative pneumonia after hip fracture surgery: a prospective cohort study. Osteoporos Int (2016) 0.76
Hip fracture, mortality risk, and cause of death over two decades. Osteoporos Int (2016) 0.76
Accuracy of evidence-based criteria for identifying an incident hip fracture in the absence of the date of injury: a retrospective database study. BMJ Open (2013) 0.76
Mortality, readmission, and reoperation after hip fracture in nonagenarians. BMC Musculoskelet Disord (2017) 0.75
The use of high-dose dual-impregnated antibiotic-laden cement with hemiarthroplasty for the treatment of a fracture of the hip: The Fractured Hip Infection trial. Bone Joint J (2016) 0.75
Risedronate's Role in Reducing Hip Fracture in Postmenopausal Women with Established Osteoporosis. Clin Med Insights Arthritis Musculoskelet Disord (2012) 0.75
Postoperative Mortality after Hip Fracture Surgery: A 3 Years Follow Up. PLoS One (2016) 0.75
Incidence, Morbidity and Mortality in Patients Older than 50 Years with Second Hip Fracture in a Jeju Cohort Study. Hip Pelvis (2014) 0.75
Identifying clusters of falls-related hospital admissions to inform population targets for prioritising falls prevention programmes. Inj Prev (2015) 0.75
Orthogeriatric co-management improves the outcome of long-term care residents with fragility fractures. Arch Orthop Trauma Surg (2016) 0.75
Co-morbidities, complications and causes of death among people with femoral neck fracture - a three-year follow-up study. BMC Geriatr (2016) 0.75
Incidence and excess mortality of hip fracture in young adults: a nationwide population-based cohort study. BMC Musculoskelet Disord (2016) 0.75
Association between secreted phosphoprotein-1 (SPP1) polymorphisms and low bone mineral density in women. PLoS One (2014) 0.75
Do fall-risk-increasing drugs have an impact on mortality in older hip fracture patients? A population-based cohort study. Clin Interv Aging (2016) 0.75
Decreases in heart rate variability are associated with postoperative complications in hip fracture patients. PLoS One (2017) 0.75
Excess mortality following hip fracture: impact of self-perceived health, smoking, and body mass index. A NOREPOS study. Osteoporos Int (2016) 0.75
Trends in hip fracture rates in Taiwan: a nationwide study from 1996 to 2010. Osteoporos Int (2016) 0.75
Excess of all-cause mortality after a fracture in type 2 diabetic patients: a population-based cohort study. Osteoporos Int (2017) 0.75
Body mass index, risk of allogeneic red blood cell transfusion, and mortality in elderly patients undergoing hip fracture surgery. Osteoporos Int (2016) 0.75
A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis (1987) 174.79
The Danish National Hospital Register. A valuable source of data for modern health sciences. Dan Med Bull (1999) 14.29
Epidemiology. When an entire country is a cohort. Science (2000) 7.93
Population-based study of survival after osteoporotic fractures. Am J Epidemiol (1993) 4.71
An estimate of the worldwide prevalence, mortality and disability associated with hip fracture. Osteoporos Int (2004) 4.24
Selection of controls in case-control studies. I. Principles. Am J Epidemiol (1992) 3.94
Mortality associated with delay in operation after hip fracture: observational study. BMJ (2006) 3.82
Mortality, disability, and nursing home use for persons with and without hip fracture: a population-based study. J Am Geriatr Soc (2002) 3.09
Prevalent vertebral deformities predict mortality and hospitalization in older women with low bone mass. Fracture Intervention Trial Research Group. J Am Geriatr Soc (2000) 2.80
Excess mortality attributable to hip fracture in white women aged 70 years and older. Am J Public Health (1997) 2.68
Race and sex differences in mortality following fracture of the hip. Am J Public Health (1992) 2.63
Prospective, multi-centre trial of mortality following general or spinal anaesthesia for hip fracture surgery in the elderly. Br J Anaesth (1987) 2.55
What is the true mortality of hip fractures? Public Health (1991) 2.52
Survival experience of aged hip fracture patients. Am J Public Health (1989) 2.46
Survival and ambulation following hip fracture. J Bone Joint Surg Am (1978) 2.31
Heparin, low molecular weight heparin and physical methods for preventing deep vein thrombosis and pulmonary embolism following surgery for hip fractures. Cochrane Database Syst Rev (2002) 2.23
Mortality following fractures in older women. The study of osteoporotic fractures. Arch Intern Med (1996) 2.05
Mortality after hip fractures. Acta Orthop Scand (1979) 2.05
Fracture risk in patients with celiac Disease, Crohn's disease, and ulcerative colitis: a nationwide follow-up study of 16,416 patients in Denmark. Am J Epidemiol (2002) 2.05
Mortality and life expectancy after hip fractures. Acta Orthop Scand (1980) 1.97
Is the delay to surgery for isolated hip fracture predictive of outcome in efficient systems? J Trauma (2006) 1.74
Gender differences in mortality after hip fracture: the role of infection. J Bone Miner Res (2003) 1.73
Determinants of reduced survival following hip fractures in men. Clin Orthop Relat Res (1995) 1.69
Incident vertebral fractures and mortality in older women: a prospective study. Osteoporos Int (2003) 1.64
Mortality and causes of death after hip fractures in The Netherlands. Neth J Med (1992) 1.63
Hip fracture among the elderly in a mixed urban and rural population. Age Ageing (1984) 1.48
Fractures after stroke. Osteoporos Int (1998) 1.47
Age and sex as determinants of mortality after hip fracture: 3,895 patients followed for 2.5-18.5 years. J Orthop Trauma (1993) 1.32
Predictors of mortality after acute hip fracture. J Gen Intern Med (1996) 1.31
The fixation and prognosis of trochanteric fractures. A randomized prospective controlled trial. Clin Orthop Relat Res (1990) 1.22
Mortality after cervical hip fracture. 3002 patients followed for 6 years. Acta Orthop Scand (1986) 1.22
The mortality and social prognosis of hip fractures. A prospective multifactorial study. Int Orthop (1994) 1.17
Mortality and morbidity associated with osteoporosis drug treatment following hip fracture. Osteoporos Int (2003) 1.10
Effects of blood transfusion on clinical and functional outcomes in patients with hip fracture. Transfusion (2003) 1.05
Hemiarthroplasty in hip fracture care: effects of surgical volume on short-term outcome. J Arthroplasty (1998) 1.01
Cardiovascular and neurological function in elderly patients sustaining a fracture of the neck of the femur. J Bone Joint Surg Br (1981) 1.00
Socioeconomic aspects of fractures within universal public healthcare: a nationwide case-control study from Denmark. Scand J Public Health (2006) 0.86
Adipocyte tissue volume in bone marrow is increased with aging and in patients with osteoporosis. Biogerontology (2001) 3.00
Cancellous bone remodeling occurs in specialized compartments lined by cells expressing osteoblastic markers. J Bone Miner Res (2001) 2.89
Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the third international workshop. J Clin Endocrinol Metab (2009) 2.69
Proton pump inhibitors, histamine H2 receptor antagonists, and other antacid medications and the risk of fracture. Calcif Tissue Int (2006) 2.33
Plasma concentrations of 25-hydroxy-vitamin D and 1,25-dihydroxy-vitamin D are related to the phenotype of Gc (vitamin D-binding protein): a cross-sectional study on 595 early postmenopausal women. Calcif Tissue Int (2005) 2.23
Fracture rates and risk factors for fractures in patients with spinal cord injury. Spinal Cord (1998) 2.07
Effects of parathyroid hormone alone or in combination with antiresorptive therapy on bone mineral density and fracture risk--a meta-analysis. Osteoporos Int (2006) 1.79
Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk. Diabetologia (2005) 1.79
Global vitamin D levels in relation to age, gender, skin pigmentation and latitude: an ecologic meta-regression analysis. Osteoporos Int (2008) 1.78
Fracture risk associated with the use of morphine and opiates. J Intern Med (2006) 1.71
Serum markers of type I collagen formation and degradation in metabolic bone disease: correlation with bone histomorphometry. J Bone Miner Res (1993) 1.57
Myopathy in bone loss of ageing: improvement by treatment with 1 alpha-hydroxycholecalciferol and calcium. Clin Sci (Lond) (1979) 1.49
Stereological considerations concerning the measurement of individual osteoid seams and resorption cavities. Bone Miner (1994) 1.47
Cohort study of risk of fracture before and after surgery for primary hyperparathyroidism. BMJ (2000) 1.47
Statins decrease bone turnover in postmenopausal women: a cross-sectional study. Eur J Clin Invest (2002) 1.46
Autosomal dominant osteopetrosis. Clin Orthop Relat Res (1993) 1.44
Familial isolated primary hyperparathyroidism. Clin Endocrinol (Oxf) (1994) 1.42
Stroke in relation to use of raloxifene and other drugs against osteoporosis. Osteoporos Int (2010) 1.42
Polymorphisms of muscle genes are associated with bone mass and incident osteoporotic fractures in Caucasians. Calcif Tissue Int (2013) 1.40
Efficacy of wheat germ lectin-precipitated alkaline phosphatase in serum as an estimator of bone mineralization rate: comparison to serum total alkaline phosphatase and serum bone Gla-protein. Calcif Tissue Int (1989) 1.39
[Costs of different intervention strategies to prevent hip fractures]. Ugeskr Laeger (1999) 1.39
Anxiolytics, sedatives, antidepressants, neuroleptics and the risk of fracture. Osteoporos Int (2006) 1.39
Fracture risk is increased in Crohn's disease, but not in ulcerative colitis. Gut (2000) 1.33
Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism. Clin Endocrinol (Oxf) (2005) 1.30
Vitamin D and its binding protein Gc: long-term variability in peri- and postmenopausal women with and without hormone replacement therapy. Scand J Clin Lab Invest (2006) 1.29
The effect of single oral doses of prednisone on the circadian rhythm of serum osteocalcin in normal subjects. J Clin Endocrinol Metab (1988) 1.29
Fracture risk in patients treated for hyperthyroidism. Thyroid (2000) 1.25
Sex differences in age-related changes in vertebral body size, density and biomechanical competence in normal individuals. Bone (1990) 1.23
Lumbar vertebral body compressive strength evaluated by dual-energy X-ray absorptiometry, quantitative computed tomography, and ashing. Bone (1999) 1.22
Age- and sex-related changes in iliac cortical bone mass and remodeling. Bone (1994) 1.19
Fractures in patients with primary idiopathic hypothyroidism. Thyroid (2000) 1.17
Biomechanical competence of vertebral trabecular bone in relation to ash density and age in normal individuals. Bone (1987) 1.17
Histomorphometric analysis of normal bone from the iliac crest. Acta Pathol Microbiol Scand A (1978) 1.16
Normal vertebral body size and compressive strength: relations to age and to vertebral and iliac trabecular bone compressive strength. Bone (1986) 1.16
Effects of vitamin D supplementation on body fat accumulation, inflammation, and metabolic risk factors in obese adults with low vitamin D levels - results from a randomized trial. Eur J Intern Med (2013) 1.14
Vitamin D insufficiency in Greenlanders on a westernized fare: ethnic differences in calcitropic hormones between Greenlanders and Danes. Calcif Tissue Int (2003) 1.14
Reconstruction of the formative site in iliac trabecular bone in 20 normal individuals employing a kinetic model for matrix and mineral apposition. Metab Bone Dis Relat Res (1984) 1.14
Fracture risk is increased in epilepsy. Acta Neurol Scand (1999) 1.13
Tetracycline double-labeling of iliac trabecular bone in 41 normal adults. Calcif Tissue Res (1978) 1.12
Age-related changes in the biochemical properties of human cancellous bone collagen: relationship to bone strength. Calcif Tissue Int (1999) 1.12
Reduced concentration of collagen reducible cross links in human trabecular bone with respect to age and osteoporosis. Bone (1996) 1.11
Missing observations in bone histomorphometry on osteoporosis: implications and suggestions for an approach. Bone (1999) 1.10
Trabecular bone remodeling and balance in primary hyperparathyroidism. Bone (1986) 1.10
Effects of 25OHD concentrations on chances of pregnancy and pregnancy outcomes: a cohort study in healthy Danish women. Eur J Clin Nutr (2012) 1.09
Effects of paracetamol, non-steroidal anti-inflammatory drugs, acetylsalicylic acid, and opioids on bone mineral density and risk of fracture: results of the Danish Osteoporosis Prevention Study (DOPS). Osteoporos Int (2011) 1.08
Soluble CD163: a marker molecule for monocyte/macrophage activity in disease. Scand J Clin Lab Invest Suppl (2002) 1.08
Assessment of bone remodeling using biochemical indicators of type I collagen synthesis and degradation: relation to calcium kinetics. Bone Miner (1994) 1.07
A randomized study on the effects of estrogen/gestagen or high dose oral calcium on trabecular bone remodeling in postmenopausal osteoporosis. Bone (1989) 1.06
Fracture risk associated with use of nonsteroidal anti-inflammatory drugs, acetylsalicylic acid, and acetaminophen and the effects of rheumatoid arthritis and osteoarthritis. Calcif Tissue Int (2006) 1.06
Reduced relative risk of fractures among users of lithium. Calcif Tissue Int (2005) 1.05
An evaluation of the quantitative parameters applied in bone histology. Acta Pathol Microbiol Scand A (1978) 1.02
Hormone replacement therapy dissociates fat mass and bone mass, and tends to reduce weight gain in early postmenopausal women: a randomized controlled 5-year clinical trial of the Danish Osteoporosis Prevention Study. J Bone Miner Res (2003) 1.02
Low serum levels of 1.25-dihydroxyvitamin D and histomorphometric evidence of osteomalacia after jejunoileal bypass for obesity. Gut (1980) 1.01
Fracture risk in patients with muscular dystrophy and spinal muscular atrophy. J Rehabil Med (2001) 1.01
Ultrastructural investigations of bone resorptive cells in two types of autosomal dominant osteopetrosis. Bone (1994) 1.00
Bone mineral density in Klinefelter syndrome is reduced and primarily determined by muscle strength and resorptive markers, but not directly by testosterone. Osteoporos Int (2010) 0.99
Correlation between the compressive strength of iliac and vertebral trabecular bone in normal individuals. Bone (1985) 0.99
Influence of hyper- and hypothyroidism, and the effects of treatment with antithyroid drugs and levothyroxine on fracture risk. Calcif Tissue Int (2005) 0.99
Effects of PTH(1-84) therapy on muscle function and quality of life in hypoparathyroidism: results from a randomized controlled trial. Osteoporos Int (2014) 0.99
Cortical bone mass, composition, and mechanical properties in female rats in relation to age, long-term ovariectomy, and estrogen substitution. Calcif Tissue Int (1993) 0.98
A model of vertebral trabecular bone architecture and its mechanical properties. Bone (1990) 0.98
Vitamin D metabolites and skeletal consequences in primary hyperparathyroidism. Clin Endocrinol (Oxf) (2007) 0.98
Reconstruction of the resorptive site in iliac trabecular bone: a kinetic model for bone resorption in 20 normal individuals. Metab Bone Dis Relat Res (1984) 0.97
Growth hormone stimulates proliferation and differentiation of normal human osteoblast-like cells in vitro. Calcif Tissue Int (1993) 0.97
Estimation of the three-dimensional wall thickness of completed remodeling sites in iliac trabecular bone. Metab Bone Dis Relat Res (1982) 0.97
Age- and gender-related differences in vertebral bone mass, density, and strength. J Bone Miner Res (1999) 0.97
Primary hyperparathyroidism: short-term changes in bone remodeling and bone mineral density following parathyroidectomy. Bone (1999) 0.96
The positive effects of zinc on skeletal strength in growing rats. Bone (2001) 0.96
Reduced fracture risk in users of thiazide diuretics. Calcif Tissue Int (2005) 0.96
Estimation of bone turnover evaluated by 47Ca-kinetics. Efficiency of serum bone gamma-carboxyglutamic acid-containing protein, serum alkaline phosphatase, and urinary hydroxyproline excretion. J Clin Invest (1985) 0.96
A tetracycline-based histomorphometric evaluation of bone resorption and bone turnover in hyperthyroidism and hyperparathyroidism. Acta Med Scand (1978) 0.96
Risk of femoral shaft and subtrochanteric fractures among users of bisphosphonates and raloxifene. Osteoporos Int (2010) 0.96
Osteon cross-sectional size in the iliac crest: variation in normals and patients with osteoporosis, hyperparathyroidism, acromegaly, hypothyroidism and treated epilepsia. Acta Pathol Microbiol Immunol Scand A (1982) 0.96
Biochemical evidence of disturbed bone metabolism and calcium homeostasis in two types of autosomal dominant osteopetrosis. Acta Med Scand (1988) 0.96
Predicting human vertebral bone strength by vertebral static histomorphometry. Bone (2002) 0.95
Bone changes in hyperthyroidism: interrelationships between bone morphometry, thyroid function and calcium-phosphorus metabolism. Acta Endocrinol (Copenh) (1977) 0.95